The TAT peptide endows PACAP with an enhanced ability to traverse bio-barriers

Neuroscience Letters

Volumn 527, Issue 1, 2012, Pages 1-5

  Yu, Rongjie ^a   Zeng, Zhixing ^a   Guo, Xiaoling ^a   Zhang, HuaHua ^b   Liu, Xiaofei ^a   Ding, Yong ^c   Chen, Jiansu ^a  

^a JINAN UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

Author keywords

Blood brain barrier; Food intake; PACAP; Protein transduction domain; TAT

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; HYBRID PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD TESTIS BARRIER; BRAIN; BRAIN BLOOD FLOW; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; EXPRESSION VECTOR; FLUORESCENCE MICROSCOPY; FOOD INTAKE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADMINISTRATION, ORAL; ANIMALS; BLOOD-AIR BARRIER; BLOOD-BRAIN BARRIER; BLOOD-TESTIS BARRIER; BRAIN; CHO CELLS; CRICETINAE; CRICETULUS; GENE PRODUCTS, TAT; HUMANS; INJECTIONS, INTRAPERITONEAL; LUNG; MALE; MICE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECOMBINANT FUSION PROTEINS; TESTIS; TISSUE DISTRIBUTION;

EID: 84866484089     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.005     Document Type: Article

References (20)

1. Banks W.A., Kastin A.J., Arimura A. Effect of spinal cord injury on the permeability of the blood-brain and blood-spinal cord barriers to the neurotropin PACAP. Experimental Neurology 1998, 151:116-123.
2. Banks W.A., Kastin A.J., Komaki G., Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP) can cross the vascular component of the blood-testis barrier in the mouse. Journal of Andrology 1993, 14:170-173.
3. Bourgault S., Vaudry D., Dejda A., Doan N.D., Vaudry H., Fournier A. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective peptide. Current Medicinal Chemistry 2009, 16:4462-4480.
4. Dietz G.P. Protection by neuroglobin and cell-penetrating peptide-mediated delivery in vivo: a decade of research. Comment on Cai et al: TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice. Experimental Neurology 2011, 231:1-10.
5. Dogrukol-Ak D., Tore F., Tuncel N. Passage of VIP/PACAP/secretin family across the blood-brain barrier: therapeutic effects. Current Pharmaceutical Design 2004, 10:1325-1340.
6. Fittipaldi A., Giacca M. Transcellular protein transduction using the Tat protein of HIV-1. Advanced Drug Delivery Reviews 2005, 57:597-608.
7. Kim T.G., Befus N., Langridge W.H. Co-immunization with an HIV-1 Tat transduction peptide-rotavirus enterotoxin fusion protein stimulates a Th1 mucosal immune response in mice. Vaccine 2004, 22:431-438.
8. Kleemann E., Neu M., Jekel N., Fink L., Schmehl T., Gessler T., Seeger W., Kissel T. Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. Journal of Controlled Release 2005, 109:299-316.
9. Lindgren M.E., Hällbrink M.M., Elmquist A.M., Langel U. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro. Biochemical Journal 2004, 377:69-76.
10. Mizushima H., Banks W.A., Dohi K., Shioda S., Matsumoto H., Matsumoto K. The effect of cardiac arrest on the permeability of the mouse blood-brain and blood-spinal cord barrier to pituitary adenylate cyclase activating polypeptide (PACAP). Peptides 1999, 20:1337-1340.
11. Mounien L., DoRego J.C., Bizet P., Boutelet I., Gourcerol G., Fournier A., Brabet P., Costentin J., Vaudry H., Jégou S. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology 2009, 34:424-435.
12. Nonaka N., Shioda S., Banks W.A. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier. Experimental Neurology 2005, 191:137-144.
13. Patel L.N., Wang J., Kim K.J., Borok Z., Crandall E.D., Shen W.C. Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin. Molecular Pharmacology 2009, 6:492-503.
14. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285:1569-1572.
15. Torchilin V.P. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Advanced Drug Delivery Reviews 2008, 60:548-558.
16. Vaudry D., Falluel-Morel A., Bourgault S., Basille M., Burel D., Wurtz O., Fournier A., Chow B.K., Hashimoto H., Galas L., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacological Reviews 2009, 61:283-357.
17. Wang H., Zhang S., Liao Z., Wang C., Liu Y., Feng S., Jiang X., Chang J. PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrier. Biomaterials 2010, 31:6589-6596.
18. Yu R., Hong A., Dai Y., Gao Y. Intein-mediated rapid purification of recombinant human pituitary adenylate cyclase activating polypeptide. Acta Biochimica et Biophysica Sinica 2004, 36:759-766.
19. Yu R., Yi T., Xie S., Hong A. Long-term administration of maxadilan improves glucose tolerance and insulin sensitivity in mice. Peptides 2008, 29:1347-1353.
20. Zhu L., Tamvakopoulos C., Xie D., Dragovic J., Shen X., Fenyk-Melody J.E., Schmidt K., Bagchi A., Griffin P.R., Thornberry N.A., Sinha Roy R. The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38). Journal of Biological Chemistry 2003, 278:22418-22423.